Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CRBU - Lawsuit filed for Investors with substantial Losses in Caribou Biosciences Inc. (NASDAQ: CRBU) shares announced by the Shareholders Foundation


CRBU - Lawsuit filed for Investors with substantial Losses in Caribou Biosciences Inc. (NASDAQ: CRBU) shares announced by the Shareholders Foundation

SAN DIEGO, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Caribou Biosciences, Inc. (NASDAQ: CRBU) shares.

Investors who suffered losses in excess of $200,000 with shares of Caribou Biosciences, Inc. (NASDAQ: CRBU) have certain options and there are short and strict deadlines running. Deadline: April 11, 2023. NASDAQ: CRBU investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On February 10, 2023, a lawsuit was filed against Caribou Biosciences, Inc. The plaintiff alleges that the Offering Documents the were issued in connection with the Company’s July 23, 2021 IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.  Additionally, the plaintiff alleges that between July 23, 2021 and December 9, 2022, the Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects.

More specifically, the plaintiff claims that the Offering Documents of the IPO and that the Defendants made false and/or misleading statements and/or failed to disclose that CB-010’s treatment effect was not as durable as Defendants had led investors to believe, that accordingly, CB-010’s clinical and commercial prospects were overstated, and that as a result, the Offering Documents and Defendants’ public statements between July 23, 2021 and December 9, 2022 were materially false and/or misleading and failed to state information required to be stated therein.

Those who purchased NASDAQ: CRBU shares should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.


Stock Information

Company Name: Caribou Biosciences Inc.
Stock Symbol: CRBU
Market: NASDAQ
Website: cariboubio.com

Menu

CRBU CRBU Quote CRBU Short CRBU News CRBU Articles CRBU Message Board
Get CRBU Alerts

News, Short Squeeze, Breakout and More Instantly...